Ferric Carboxymaltose PDE report and OEL report profile
Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
9007-72-1
Molecular formula
Not available
Molecular weight
~150000 g/mol
Drug class
Intravenous iron(III)-carbohydrate complexparenteral iron replacement agent
Mechanism of action
A stable colloidal iron(III)-hydroxide complex with carboxymaltose carbohydrate. Following intravenous administration, iron is taken up by reticuloendothelial cells and made available for transferrin binding and incorporation into haemoglobin and iron stores; it is not a simple dissociating iron salt.
Indications / reported uses
Treatment of iron-deficiency anaemia in adults and eligible paediatric patients when oral iron is ineffective, not tolerated or rapid iron replacement is needed
Treatment of iron deficiency in selected patients with heart failure where the specific formulation is authorised; use and dosing are product-label specific
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Ferric Carboxymaltose PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Ferric Carboxymaltose Permitted Daily Exposure (PDE) report (the Ferric Carboxymaltose PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Ferric Carboxymaltose Occupational Exposure Limit (OEL) report (the Ferric Carboxymaltose OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.